Clinical trial
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With…
NCT00064194 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00064194 |
|---|---|
| Title | Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia |
| Official title | A Double-Blind, Placebo-Controlled, Randomized Study Of Combination Vitamin E, Selenium And Soy Protein Product In Subjects With High Grade Prostatic Intraepithelial Neoplasia |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Precancerous/Nonmalignant Condition, Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | selenium, soy protein isolate, vitamin E |
| Enrollment | 310 |
| Start date | Nov 28, 2001 |
| Primary completion | Apr 30, 2008 |
| Completion | Apr 30, 2008 |
| First posted | Jul 9, 2003 |
| Last update posted | Apr 3, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: